10.94
-0.09(-0.82%)
Currency In USD
| Previous Close | 11.04 |
| Open | 11.25 |
| Day High | 11.26 |
| Day Low | 10.66 |
| 52-Week High | 14.06 |
| 52-Week Low | 4.02 |
| Volume | 423,894 |
| Average Volume | 853,331 |
| Market Cap | 588.46M |
| PE | 8.36 |
| EPS | 1.32 |
| Moving Average 50 Days | 11.93 |
| Moving Average 200 Days | 8.93 |
| Change | -0.01 |
If you invested $1000 in Emergent BioSolutions Inc. (EBS) 10 years ago, it would be worth $307.41 as of February 12, 2026 at a share price of $11.03. Whereas If you bought $1000 worth of Emergent BioSolutions Inc. (EBS) shares 5 years ago, it would be worth $88.11 as of February 12, 2026 at a share price of $11.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc.
1 hours ago
GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year of
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
GlobeNewswire Inc.
Jan 14, 2026 1:00 PM GMT
Since the U.S. prescription launch of NARCAN® Nasal Spray in 2016, the medicine has been trusted as a safe, effective way to reverse opioid overdoses, and today, new solutions like the NARCAN® carrying case aims to make accessibility paramount - ‘Tru
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
GlobeNewswire Inc.
Jan 12, 2026 12:30 PM GMT
GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions, Inc. (NYSE: EBS) announced it made a voluntary prepayment of $100 million under its outstanding term loan facility in late December 2025 using cash on hand. “This sig